期刊文献+

度洛西汀联合奥替溴铵治疗肠易激综合征的观察 被引量:5

下载PDF
导出
摘要 目的:探讨度洛西汀联合奥替溴铵治疗伴抑郁症状肠易激综合征(IBS)的有效性和安全性。方法:将78例IBS患者随机分为两组,治疗组予度洛西汀+奥替溴铵口服,对照组奥替溴铵口服,治疗6周后观察疗效,治疗前后行24项汉密尔顿量表评分(HAMD)测定。结果:治疗前治疗组和对照组HAMD分值无统计学差异(P>0.05),治疗后两组HAMD分值有统计学差异(P<0.05),两组治疗总有效率有统计学差异(P<0.05)。治疗组无明显不良反应。结论:度洛西汀联合奥替溴铵治疗IBS安全有效,有较好的依从性。
出处 《实用医学杂志》 CAS 北大核心 2012年第17期2950-2951,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献6

  • 1Longstreth G F, Thompson W G, Chey W D, et al. Functional bowel disorders [J]. Gastroenterol, 2006, 130(5) : 1480-1491.
  • 2Heymann-M6nnikes I, Arnold R, Florin I, et al. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome [ J ]. Am J Gastroenterol, 2000,95 (6) : 981-994.
  • 3Spence M J, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome:a prospective investigation of patients with gastroenteritis [Jl. Gut, 2007,56 (8) : 1066- 1071.
  • 4Ringel Y. New directions in brain imaging research in functional gastrointestinal disorders [J]. Dig Dis, 2006,24 (3-4) :278- 285.
  • 5Wilder-Smith C H, Schindler D, Lovblad K, et al. Brain functional magneticresonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls[J]. Gut, 2004,53(10) : 1595-1600.
  • 6Mayer E A. Gut feelings: the emerging biology of gut-brain communication [ J ]. Nat Rev Neurosci, 2011,12 ( 8 ) : 453-466.

同被引文献68

  • 1张茹,王福贤.肠易激综合征患者IL-8和TNF-α含量变化的意义[J].临床消化病杂志,2004,16(4):167-168. 被引量:31
  • 2梁荣新,郑琴芳,梁列新,张法灿.肠易激综合征与胃肠激素的关系[J].中国综合临床,2004,20(8):702-703. 被引量:32
  • 3张小琴.单兆伟教授治疗泄泻型肠易激综合征经验拾萃[J].江西中医药,2006,37(4):9-10. 被引量:2
  • 4文红旗.氟西汀佐治腹泻型肠易激综合征疗效观察[J].山西职工医学院学报,2006,16(3):33-34. 被引量:3
  • 5傅关孺.补脾益肠丸为主治疗腹泻型肠易激综合征疗效观察[J].中医药临床杂志,2007,19(5):458-458. 被引量:11
  • 6Vlieger AM, Vanden Berg MM, Menko-Frankenhuis C,et al. No change in rectal sensitivity after gut-directedhypnotherapy in children with functional abdominal pain or irritable bowel syndrome[J].Am J Gastroen- terol,2010,105(1):213-218.
  • 7Dainty AD, Allcock N, Cooper J. Study of irritable bowel syndrome and co-existing psychological ill- ness. Nurse Res ,2014, 21:27-31 [PMID: 24673350].
  • 8Martinez-Martinez LA, Mora T, Vargas A, Fuentes- Iniestra M, MartLnez-Lavin M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and intersti- tial cystitis: a review of case-control studies. J Clin Rheumatol ,2014, 20:146-150 [PMID: 24662556 DOI: 10.7748/nr2014.03.21.4.27.e1228].
  • 9Darkoh C, Comer L, Zewdie G, Harold S, Snyder N, Dupont HL. Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One ,2014, 9:e93144 [PMID: 24667736 DOI: 10.1371/journal.pone.0093144].
  • 10Ishihara S, Tada Y, Fukuba N, Oka A, Kusunoki R, Mishima Y, Oshima N, Moriyama I, Yuki T, Ka- washima K, Kinoshita Y. Pathogenesis of irritable bowel syndrome--review regarding associated in- fection and immune activation. Digestion ,2013, 87: 204-211 [PMID: 23712295 DOI: 10.1159/000350054].

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部